Synthesis and analysis of small molecules to restrain the function of tissue factor within tumour cells

Oluremi I Adeniran1, Mohammad A Mohammad2, Sophie Featherby2

  • 1Department of Chemistry, University of Hull, HU6 7RX Hull, UK.

Insights

Novel small molecules targeting prolyl-protein cis/trans isomerase 1 (Pin1) were developed. Two compounds effectively regulated tissue factor (TF) activity and induced apoptosis in cancer cells, suggesting potential for targeted cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Prolyl-protein cis/trans isomerase 1 (Pin1) activity is linked to tissue factor (TF) release.
  • TF accumulation within cells can have significant biological consequences.
  • Targeting Pin1 offers a potential strategy to modulate TF function.

Purpose of the Study:

  • To design and synthesize novel small molecules inhibiting Pin1.
  • To evaluate the effects of these compounds on TF activity, release, and cellular apoptosis.
  • To assess the specificity of these compounds on cancer versus primary cells.

Main Methods:

  • Synthesis of four novel amide compounds with varying amino-termini (D-alanine, D-tryptophan, D-phenylalanine, D-tyrosine).
  • Treatment of MDA-MB-231 (cancer) and primary cells with synthesized compounds.
  • Assays to measure cell-surface TF activity, TF antigen, TF incorporation into microvesicles, Pin1 binding to TF peptide, Pin1 isomerase activity, and apoptosis markers (p53, Bax).

Main Results:

  • Compounds 4b (D-tryptophan) and 4d (D-tyrosine) reduced cell-surface TF activity and Pin1 binding to TF peptide.
  • Compound 4d decreased TF antigen and microvesicle incorporation; compounds 4a and 4b increased TF release.
  • Compounds 4b and 4d induced apoptosis in MDA-MB-231 cells by increasing p53 and Bax, without affecting primary endothelial cells.

Conclusions:

  • Novel small molecules were identified that modulate TF function.
  • Compounds 4b and 4d show promise in regulating TF activity and inducing cancer cell apoptosis.
  • These compounds may offer a therapeutic strategy for TF-mediated tumor growth with minimal impact on normal vascular cells.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K